pharmaphorum - Robuta Search

https://pharmaphorum.com/tag/patent-litigation patent litigation | pharmaphorum patent litigation pharmaphorum https://pharmaphorum.com/news/texas-suit-claims-lilly-bribed-providers-prescribe-drugs Texas suit claims Lilly bribed providers to prescribe drugs | pharmaphorum Eli Lilly has been accused of giving illegal inducements to encourage medical providers in Texas to prescribe its medicines. prescribe drugs texas suit claims lilly https://pharmaphorum.com/tag/melanoma melanoma | pharmaphorum melanoma pharmaphorum https://pharmaphorum.com/news/south-africas-maternal-health-network-momconnect-launches-messenger-bot Facebook chatbot to help pregnant women in South Africa | pharmaphorum The service will provide a live helpdesk for expectant mothers. to help pregnant women south africa facebook chatbot https://pharmaphorum.com/tag/live-event-coverage live event coverage | pharmaphorum |live event coverage live event coverage pharmaphorum https://pharmaphorum.com/tag/csl CSL | pharmaphorum csl pharmaphorum https://pharmaphorum.com/tag/luveltamab-tazevibulin luveltamab tazevibulin | pharmaphorum |luveltamab tazevibulin pharmaphorum https://pharmaphorum.com/tag/patients-and-partnerships-2020 Patients and Partnerships 2020 | pharmaphorum |Patients and Partnerships 2020 patients partnerships pharmaphorum https://pharmaphorum.com/tag/radiobiology radiobiology | pharmaphorum radiobiology pharmaphorum https://pharmaphorum.com/news/vertex-bags-fda-okay-its-non-opioid-pain-drug Vertex bags FDA okay for its non-opioid pain drug | pharmaphorum Vertex gets FDA approval for its non-opioid pain drug suzetrigine, the first new class of pain medicine in the US in more than 20 years. vertex bags fda okay https://pharmaphorum.com/news/scientists-issue-call-arms-over-antifungal-resistance Scientists issue call to arms over antifungal resistance | pharmaphorum Infectious disease experts from around the world are calling for concerted action to combat a "silent surge" in resistance to antifungal drugs. call to arms scientists issue antifungal resistance https://pharmaphorum.com/news/psychedelics-and-mental-health-time-now Psychedelics and mental health: The time is now? | pharmaphorum the time is now mental health psychedelics pharmaphorum https://pharmaphorum.com/digital/blockchain-healthcare-electronic-medical-records How blockchain can revolutionise medical records and save lives | pharmaphorum Balancing medical privacy with ease of access for healthcare professionals is a challenge, but technology could provide the solution, says Aleph Zero... medical records blockchain save lives pharmaphorum https://pharmaphorum.com/news/ai-medtech-specialist-firefly-lists-nasdaq-after-merger AI medtech specialist Firefly lists on Nasdaq after merger | pharmaphorum Firefly Neuroscience lists on Nasdaq via a $45m merger with IT firm WaveDancer, as it rolls out an AI-powered platform for managing brain function. ai medtech specialist firefly lists https://pharmaphorum.com/views-analysis-patients/pharma-highlights-2019-look-ahead-2020 Pharma highlights from 2019 and a look ahead to 2020 | pharmaphorum Paul Tunnah looks at the trends that defined this year in pharma and what they might mean for 2020 a look ahead pharma highlights https://pharmaphorum.com/news/otsuka-grows-neuroplastogens-1225bn-transcend-buy Otsuka grows in neuroplastogens with $1.225bn Transcend buy | pharmaphorum Otsuka has agreed to acquire Transcend Therapeutics and its MDMA-based neuroplastogen drug candidate for PTSD, heading for phase 3 trials otsuka grows transcend buy pharmaphorum https://wellmark.com.au/blog/uncategorised/pharmaphorum-article-is-commoditisation-killing-med-comms/ Pharmaphorum article: is commoditisation killing med comms? - Wellmark pharmaphorum article killing med comms https://pharmaphorum.com/news/beigenes-brukinsa-tops-imbruvica-in-head-to-head-contest BeiGene's Brukinsa tops Imbruvica in head-to-head contest | pharmaphorum beigene brukinsa tops imbruvica head https://pharmaphorum.com/news/novo-lilly-sign-mfn-pricing-deal-trump-administration Novo, Lilly sign MFN pricing deal with Trump administration | pharmaphorum The pricing agreement between Novo Nordisk and Eli Lilly and the Trump administration on GLP-1 drugs for diabetes and obesity has arrived. trump administration novo lilly sign mfn https://pharmaphorum.com/market-access/windsor-framework-insights-regulatory-shift-medicines The Windsor Framework: Insights on the regulatory shift for medicines | pharmaphorum Explore the Windsor Framework and gain insights into the evolving regulatory landscape for medicines. Understand the role of regulatory agencies in shaping the... the windsor framework insights regulatory shift https://pharmaphorum.com/news/novavax-investor-withdraws-proxy-fight-after-sanofi-deal Novavax investor withdraws proxy fight after Sanofi deal | pharmaphorum Shah Capital has withdrawn a proxy campaign against the re-election of directors at vaccines firm Novavax in the wake of its $1.2 billion alliance with Sanofi. novavax investor withdraws proxy fight https://pharmaphorum.com/news/nhs-grants-fast-track-access-to-takedas-lung-cancer-drug-exkivity NHS grants fast-track access to Takeda's lung cancer drug Exkivity | pharmaphorum Takeda has secured UK approval for its lung cancer therapy Exkivity, with an NHS access deal that could see it prescribed to patients within the next few... https://pharmaphorum.com/tag/cryogenic-logistics cryogenic logistics | pharmaphorum |cryogenic logistics cryogenic logistics pharmaphorum https://pharmaphorum.com/news/vertex-pharma-makes-progress-in-quest-for-non-opioid-pain-drug Vertex Pharma makes progress in quest for non-opioid pain drug | pharmaphorum The search for an alternative to opioid drugs for pain relief has dragged one for decades, with little success, but Vertex Pharma thinks that could be about to... https://pharmaphorum.com/rd/future-patient-centric-access-here The Future of Patient-Centric Access is Here! | pharmaphorum the future is here patient centric access https://pharmaphorum.com/patients/event Patients Events | pharmaphorum Connect with the pharma community through patient-focused industry events. Stay updated on conferences, seminars, and networking opportunities. patients events pharmaphorum https://pharmaphorum.com/tag/bias bias | pharmaphorum bias pharmaphorum https://pharmaphorum.com/oncology/cancer-vaccines-providing-the-edge-in-oncology Cancer vaccines: providing the edge in oncology | pharmaphorum In this article, Ben Hargreaves looks into the promise of cancer vaccines and how this treatment modality may offer advantages over existing immunotherapies in... cancer vaccines the edge providing oncology pharmaphorum https://pharmaphorum.com/tag/medtech medtech | pharmaphorum medtech pharmaphorum https://pharmaphorum.com/tag/cancer-control Cancer control | pharmaphorum cancer control pharmaphorum https://pharmaphorum.com/rd/rd-procurement-outsourcing-biopharma-west-summit R&D Procurement & Outsourcing in Biopharma West Summit | pharmaphorum An event to empower you with the knowledge and tools to excel in procurement and outsourcing r d procurement outsourcing west summit biopharma pharmaphorum https://pharmaphorum.com/tag/paul-tunnah Paul Tunnah | pharmaphorum paul pharmaphorum https://pharmaphorum.com/news/gsk-takes-rsv-jab-rivalry-pfizer-courts GSK takes RSV jab rivalry with Pfizer into the courts | pharmaphorum the courts gsk takes rsv jab https://pharmaphorum.com/tag/pat pat | pharmaphorum pat pharmaphorum https://pharmaphorum.com/tag/perry-health Perry Health | pharmaphorum perry health pharmaphorum https://pharmaphorum.com/tag/analysis analysis | pharmaphorum analysis pharmaphorum https://pharmaphorum.com/tag/patient-reported-outcome-measures Patient reported outcome measures | pharmaphorum |Patient reported outcome measures outcome measures patient reported pharmaphorum https://pharmaphorum.com/rd/week-clinical-trials-2nd-5th-january-2024 This week in clinical trials: 2nd-5th January 2024 | pharmaphorum Stay up to date with the latest developments in clinical trials, including updates on Vicore, Mundipharma, Agios, Ultragenyx, EG 427, Orion, and MSD. Find out... this week clinical trials january pharmaphorum https://pharmaphorum.com/tag/ecopipam ecopipam | pharmaphorum ecopipam pharmaphorum https://pharmaphorum.com/tag/environmental-monitoring environmental monitoring | pharmaphorum |environmental monitoring environmental monitoring pharmaphorum https://pharmaphorum.com/tag/revolution-medicines Revolution Medicines | pharmaphorum |Revolution Medicines revolution medicines pharmaphorum https://pharmaphorum.com/tag/nsclc NSCLC | pharmaphorum nsclc pharmaphorum https://pharmaphorum.com/news/biolinq-bags-fda-okay-autonomous-glucose-sensor Biolinq bags FDA okay for autonomous glucose sensor | pharmaphorum Biolinq gets an FDA green light for its autonomous, needle-free continuous glucose monitor, plus a round-up of other medtech developments. bags fda okay autonomous glucose https://pharmaphorum.com/news/sumitomos-novel-schizophrenia-drug-flunks-phase-3-test Sumitomo's novel schizophrenia drug flunks phase 3 test | pharmaphorum sumitomo novel schizophrenia drug phase https://pharmaphorum.com/digital/seven-pillars-genai-enterprise-level-value-generation Seven pillars of GenAI for enterprise-level value generation | pharmaphorum Discover the seven essential pillars of GenAI for generating value at an enterprise level and leveraging artificial intelligence to drive innovation and growth. for enterprise seven pillars genai level https://pharmaphorum.com/news/one-drop-founder-announces-broad-market-cgm-frontiers-stage One Drop founder announces broad market CGM on Frontiers stage | pharmaphorum broad market one drop founder announces https://pharmaphorum.com/tag/brensocatib brensocatib | pharmaphorum pharmaphorum https://pharmaphorum.com/tag/digital-transformation Digital transformation | pharmaphorum |Digital transformation digital transformation pharmaphorum https://www.finanznachrichten.de/nachrichten-medien/pharmaphorum-8.htm pharmaphorum | Nachrichten Aktuelle pharmaphorum News: Kidney biotech R1's $78m debut, and other biofinancings pharmaphorum nachrichten https://pharmaphorum.com/tag/india India | pharmaphorum india pharmaphorum https://pharmaphorum.com/news/real-chemistry-hires-new-global-chief-inclusion-and-health-equity-officerd Real Chemistry hires new global chief inclusion and health equity officer | pharmaphorum Global health innovation company Real Chemistry has announced the appointment of Mary Stutts to lead its diversity, equity and inclusion strategy. real chemistry https://pharmaphorum.com/ pharmaphorum | News & views on pharma and biotech’s evolving future pharmaphorum news views evolving future https://pharmaphorum.com/tag/website website | pharmaphorum pharmaphorum https://pharmaphorum.com/news/fda-seeks-input-opaque-priority-voucher-scheme FDA seeks input into 'opaque' priority voucher scheme | pharmaphorum FDA seeks public input on controversial priority voucher scheme amid concerns about its transparency and legality. voucher scheme fda seeks input opaque https://pharmaphorum.com/news/cellcentric-pockets-220m-blood-cancer-programme CellCentric pockets $220m for blood cancer programme | pharmaphorum CellCentric has raised $220 million in a Series D financing that will help fund pivotal trials of p300/CBP inhibitor inobrodib in multiple myeloma. blood cancer pockets programme pharmaphorum https://pharmaphorum.com/news/phti-review-digital-hypertension-mental-health-tools PHTI to review digital hypertension, mental health tools | pharmaphorum Peterson Health Technology Institute will review the clinical effectiveness and economic impact of digital health technologies (DHTs) for hypertension and... to review mental health digital hypertension tools https://pharmaphorum.com/views-and-analysis/digital-health-round-artificial-solution-diabetes Digital Health Round-up: an artificial future for diabetes | pharmaphorum In this week's digital health round-up: artificial pancreas trials begin, Chan-Zuckerberg Biohub enrolls first investigator cohort, and more. digital health round up for diabetes artificial future https://pharmaphorum.com/tag/bristol-myers-squibb Bristol Myers Squibb | pharmaphorum |Bristol Myers Squibb bristol myers squibb pharmaphorum https://pharmaphorum.com/news/uk-hospital-introduces-tytocare-remote-medical-exam-device UK hospital introduces TytoCare remote medical exam device | pharmaphorum A UK hospital has introduced a modular device allowing for remote examinations for patients with acute and worsening chronic conditions. uk hospital introduces tytocare remote https://pharmaphorum.com/news/az-grabs-licence-ionis-nash-drug-heads-clinic AZ grabs licence as Ionis NASH drug heads to the clinic | pharmaphorum Could antisense drug be a fatty liver disease blockbuster? https://pharmaphorum.com/news/novo-joins-lilly-asking-fda-ban-glp-1-compounding Novo joins Lilly in asking FDA for ban on GLP-1 compounding | pharmaphorum Novo Nordisk has asked the FDA to stop compounding pharmacies making cheaper versions of its semaglutide-based therapies for obesity and diabetes. https://pharmaphorum.com/news/jazz-buys-kras-inhibitors-redx-880m-deal Jazz buys KRAS inhibitors from Redx in $880m deal | pharmaphorum Jazz Pharmaceuticals has paid $10m upfront for a KRAS inhibitor programme from UK biotech Redx Pharma that extends its targeted cancer therapy pipeline. kras inhibitors jazz redx deal pharmaphorum https://pharmaphorum.com/tag/duopa Duopa | pharmaphorum pharmaphorum https://pharmaphorum.com/views-and-analysis/what-doctors-say-about-apple-carekit What doctors say about Apple CareKit | pharmaphorum Following the success of its open source ResearchKit, Apple is launching CareKit for app developers, which will not rely solely on patient reported outcomes to... what doctors say about apple carekit pharmaphorum https://pharmaphorum.com/tag/pharming Pharming | pharmaphorum pharming pharmaphorum https://pharmaphorum.com/tag/irhythm-technologies iRhythm Technologies | pharmaphorum |iRhythm Technologies irhythm technologies pharmaphorum https://pharmaphorum.com/rd/embracing-diversity-psychiatry-and-neurology-clinical-trials Embracing diversity in psychiatry and neurology clinical trials | pharmaphorum Embracing diversity in psychiatry and neurology clinical trials is crucial for ensuring that treatments are effective for all populations. Learn about the... embracing diversity clinical trials psychiatry neurology pharmaphorum https://pharmaphorum.com/news/hhs-fda-drop-major-dtc-advertising-policy-changes HHS, FDA drop major DTC advertising policy changes | pharmaphorum HHS and FDA announced a new policy change that would require pharma companies to list drug information much more extensively in broadcast ads. advertising policy hhs fda drop major https://pharmaphorum.com/views-and-analysis/with-landmark-approval-on-horizon-spotlight-on-cryogenic-logistics-intensifies With landmark approval, spotlight on cryogenic logistics intensifies | pharmaphorum The cell and gene therapy (CGT) industry achieved a significant milestone at the end of 2022: the first approval of an allogeneic T-cell therapy in the world. spotlight on cryogenic logistics landmark approval pharmaphorum https://pharmaphorum.com/tag/vaccinations vaccinations | pharmaphorum vaccinations pharmaphorum https://pharmaphorum.com/tag/denali-therapeutics Denali Therapeutics | pharmaphorum |Denali Therapeutics denali therapeutics pharmaphorum